Pediatric oligodendrogliomas: A study of molecular alterations on 1p and 19q using fluorescence in situ hybridization

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 5, 2003, Pages 530-537

  Raghavan, Ravi ^a   Balani, Jyoti ^a   Perry, Arie ^d   Margraf, Linda ^c   Vono, Mary B ^a   Cai, Dan X ^d   Wyatt, Robert E ^b   Rushing, Elisabeth J ^e   Bowers, Daniel C ^c   Hynan, Linda S ^b   White III, Charles L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Chromosome 19q; Chromosome 1p; Fluorescence in situ hybridization (FISH); Molecular genetics; Pediatric oligodendroglioma

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CAUSE OF DEATH; CHEMOSENSITIVITY; CHILD; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; HUMAN; HUMAN CELL; MALE; MOLECULAR GENETICS; OLIGODENDROGLIOMA; PATHOGENESIS; POLYSOME; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0037884872     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.5.530     Document Type: Article

References (24)

1. Bowers DC, Doxey DL, Mulne AF, Weprin B, Bruce DA. Margraf L. Supratentorial Oligodendrogliomas In Children And Adolescents. J Pediatr Neurosurg (in press)
2. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991. J Neurosurg 1998;88:1-10
3. Hill JR, Kuriyama N, Kuriyama H, Israel MA. Molecular genetics of brain tumors. Arch Neurol 1999;56:439-41
4. Razack N, Baumgartner J, Bruner J. Pediatric oligodendrogliomas. Pediatr Neurosurg 1998;28:121-29
5. Tice H, Barnes PD, Goumnerova L, Scott RM, Tarbell NJ. Pediatric and adolescent oligodendrogliomas. AJNR Am J Neuroradiol 1993; 14:1293-1300
6. Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999;18:4144-52
7. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-79
8. Husemann K, Wolter M, Buschges R, Bostrom J, Sabel M, Reifenberger G. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors. J Neuropathol Exp Neurol 1999; 58:1041-50
9. Mai M, Huang H, Reed C, et al. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 parm deletions. Genomics 1998;51:359-63
10. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis. Clin Cancer Res 2001;7:839-45
11. Watanabe T, Yokoo H, Yokoo M, Yonekawa Y, Kleihues P. Ohgaki H., Concurrent inactivation of RB 1 and TP53 pathways in anaplastic oligodendrogliomas. J Neuropathoi Exp Neurol 2001;60:1181-89
12. Smith JS, Tachibana I, Pohl U, et al. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 2000; 64:44-50
13. Hoang-Xuan K, He J, Huguet S, et al. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 2001;57:1278-81
14. Wolter M, Reifenberger J, Blaschke B. et al. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF. and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. J Neuropathol Exp Neurol 2001;60:1170-80
15. Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 2001;159:359-67
16. Chan AS, Leung SY, Wong MP. et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 1998;22:816-26
17. Smith JS, Tachibana I, Lee HK, et al. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosomes Cancer 2000;29:16-25
18. Roberts P, Chumas PD, Picton S, Bridges L, Livingstone JH, Sheridan E. A review of the cytogenetics of 58 pediatric brain tumors. Cancer Genet Cytogenet 2001;131:1-12
19. Bhattacharjee MB, Armstrong DD, Vogel H, Cooley LD., Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 1997;97:39-53
20. Reifenberger G, Kros JM, Burger PC, Louis DN, Collins VP. Oligodendroglial tumours and mixed gliomas. In: Kleihues P, Cavenee WK, eds. Pathology and genetics. Tumours of the nervous system. Lyon, France: IARC 2002;1:55-69
21. Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW. Ancillary FISH analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 2003; 8:1-9
22. Raghavan R, White CL, III, Rogers B, Coimbra C, Rushing EJ. Alpha-synuclein expression in central nervous system tumors showing neuronal or mixed neuronal/glial differentiation. J Neuropathol Exp Neurol 2000;59:490-94
23. Burger PC, Minn AY, Smith JS, et al. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Mod Pathol 2001;14:842-53
24. Daumas-Duport C. Scheithauer BW, Chodkiewicz JP, Laws ER, Jr,Vedrenne C. Dysembryoplastic neuroepithelial tumor: A surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988;23:545-56